- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
141 Clinical Trials near Havre, MT
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerApalutamide + Targeted Radiation for Prostate Cancer
Trial Details
Key Eligibility Criteria
804 Participants Needed
Chemotherapy + Radiotherapy for Esophageal and Gastric Cancer
Trial Details
Key Eligibility Criteria
314 Participants Needed
MRI Monitoring vs. Preventive Brain Radiation for Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
668 Participants Needed
Apalutamide + Hormone and Radiation Therapies for Prostate Cancer
Trial Details
Key Eligibility Criteria
586 Participants Needed
Vitamin D3 + Chemotherapy + Bevacizumab for Colorectal Cancer
Trial Details
Key Eligibility Criteria
455 Participants Needed
Lenalidomide +/- Daratumumab for Multiple Myeloma
Trial Details
Key Eligibility Criteria
1100 Participants Needed
ctDNA Testing for Colon Cancer Treatment Prediction
Trial Details
Key Eligibility Criteria
635 Participants Needed
Lenalidomide + Dexamethasone +/- Daratumumab for Multiple Myeloma
Trial Details
Key Eligibility Criteria
288 Participants Needed
Rituximab + Stem Cell Transplant for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
689 Participants Needed
Radiation Therapy vs Observation for Meningioma
Trial Details
Key Eligibility Criteria
163 Participants Needed
Radiation vs. Radiation + Lymph Node Dissection for Breast Cancer
Trial Details
Key Eligibility Criteria
2012 Participants Needed
RSV Vaccine for Respiratory Syncytial Virus
Trial Details
Key Eligibility Criteria
550 Participants Needed
RSV Vaccine for Infants and Toddlers
Trial Details
Key Eligibility Criteria
2226 Participants Needed
RSV Vaccine for Infants and Toddlers
Trial Details
Key Eligibility Criteria
6300 Participants Needed
Nivolumab + Chemotherapy for Anal Cancer
Trial Details
Key Eligibility Criteria
205 Participants Needed
Ipilimumab + Nivolumab + Radiation for Glioblastoma
Trial Details
Key Eligibility Criteria
159 Participants Needed
Ozanimod for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
250 Participants Needed
Stereotactic Radiosurgery for Brain Metastasis
Trial Details
Key Eligibility Criteria
242 Participants Needed
Durvalumab + Chemoradiation for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
660 Participants Needed
Venetoclax + Chemotherapy for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
363 Participants Needed
Why Other Patients Applied
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
De-intensified Radiation Therapy + Cisplatin/Nivolumab for Oropharyngeal Cancer
Trial Details
Key Eligibility Criteria
384 Participants Needed
Immunotherapy + Chemotherapy for Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
994 Participants Needed
Atezolizumab + Chemoradiation for Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
544 Participants Needed
Pembrolizumab + Chemotherapy for Lung Cancer
Trial Details
Key Eligibility Criteria
600 Participants Needed
Immunotherapy + Cabozantinib for Advanced Kidney Cancer
Trial Details
Key Eligibility Criteria
1175 Participants Needed
Chemoradiotherapy + Atezolizumab for Bladder Cancer
Trial Details
Key Eligibility Criteria
475 Participants Needed
Venetoclax + Ibrutinib + Obinutuzumab for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
465 Participants Needed
Pembrolizumab for Skin Cancer
Trial Details
Key Eligibility Criteria
280 Participants Needed
Daunorubicin + Cytarabine ± Uproleselan for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
670 Participants Needed
Combination Therapy for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
720 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do clinical trials in Havre, MT pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do clinical trials in Havre, MT work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Havre, MT 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Havre, MT is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Havre, MT several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a medical study in Havre, MT?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest clinical trials in Havre, MT?
Most recently, we added RSV Vaccine for Respiratory Syncytial Virus, Radiation Therapy for Cancer with Bone Metastasis and Durvalumab for Lung Cancer to the Power online platform.